Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018

2018
Authors
Schliephake, Henning
Sicilia, Alberto
Al Nawas, Bilal

Donos, Nikos
Gruber, Reinhard

Jepsen, Soren
Milinković, Iva

Mombelli, Andrea
Navarro, Jose M.
Quirynen, Marc
Rocchietta, Isabella
Schiodt, Morten
Schou, Soren
Stahli, Alexandra
Stavropoulos, Andreas
Article (Published version)

Metadata
Show full item recordAbstract
Objectives: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. Materials and Methods: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. Results: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengt...hs and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stahli A, Strauss FJ, Gruber R. (2018) The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stahli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. (2018) What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiodt, Klinge B. (2018) The effect of antiresorptive drugs on implant therapy: a systematic review.
Keywords:
alveolar ridge preservation / antiresorptive drugs / bisphosphonates / corrosion / dental implants / guided bone regeneration sinus floor elevation / hormone replacement therapy / implant therapy / medication-related osteonecrosis of the jaws / peri-implantitis / platelet-rich fibrin / platelet-rich plasma / systematic review / titaniumSource:
Clinical Oral Implants Research, 2018, 29, 93-99Publisher:
- Wiley, Hoboken
DOI: 10.1111/clr.13270
ISSN: 0905-7161
PubMed: 30306683
WoS: 000446982400006
Scopus: 2-s2.0-85054780108
Collections
Institution/Community
Stomatološki fakultetTY - JOUR AU - Schliephake, Henning AU - Sicilia, Alberto AU - Al Nawas, Bilal AU - Donos, Nikos AU - Gruber, Reinhard AU - Jepsen, Soren AU - Milinković, Iva AU - Mombelli, Andrea AU - Navarro, Jose M. AU - Quirynen, Marc AU - Rocchietta, Isabella AU - Schiodt, Morten AU - Schou, Soren AU - Stahli, Alexandra AU - Stavropoulos, Andreas PY - 2018 UR - https://smile.stomf.bg.ac.rs/handle/123456789/2283 AB - Objectives: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. Materials and Methods: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. Results: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stahli A, Strauss FJ, Gruber R. (2018) The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stahli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. (2018) What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiodt, Klinge B. (2018) The effect of antiresorptive drugs on implant therapy: a systematic review. PB - Wiley, Hoboken T2 - Clinical Oral Implants Research T1 - Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018 VL - 29 SP - 93 EP - 99 DO - 10.1111/clr.13270 ER -
@article{ author = "Schliephake, Henning and Sicilia, Alberto and Al Nawas, Bilal and Donos, Nikos and Gruber, Reinhard and Jepsen, Soren and Milinković, Iva and Mombelli, Andrea and Navarro, Jose M. and Quirynen, Marc and Rocchietta, Isabella and Schiodt, Morten and Schou, Soren and Stahli, Alexandra and Stavropoulos, Andreas", year = "2018", abstract = "Objectives: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. Materials and Methods: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. Results: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stahli A, Strauss FJ, Gruber R. (2018) The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stahli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. (2018) What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiodt, Klinge B. (2018) The effect of antiresorptive drugs on implant therapy: a systematic review.", publisher = "Wiley, Hoboken", journal = "Clinical Oral Implants Research", title = "Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018", volume = "29", pages = "93-99", doi = "10.1111/clr.13270" }
Schliephake, H., Sicilia, A., Al Nawas, B., Donos, N., Gruber, R., Jepsen, S., Milinković, I., Mombelli, A., Navarro, J. M., Quirynen, M., Rocchietta, I., Schiodt, M., Schou, S., Stahli, A.,& Stavropoulos, A.. (2018). Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018. in Clinical Oral Implants Research Wiley, Hoboken., 29, 93-99. https://doi.org/10.1111/clr.13270
Schliephake H, Sicilia A, Al Nawas B, Donos N, Gruber R, Jepsen S, Milinković I, Mombelli A, Navarro JM, Quirynen M, Rocchietta I, Schiodt M, Schou S, Stahli A, Stavropoulos A. Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018. in Clinical Oral Implants Research. 2018;29:93-99. doi:10.1111/clr.13270 .
Schliephake, Henning, Sicilia, Alberto, Al Nawas, Bilal, Donos, Nikos, Gruber, Reinhard, Jepsen, Soren, Milinković, Iva, Mombelli, Andrea, Navarro, Jose M., Quirynen, Marc, Rocchietta, Isabella, Schiodt, Morten, Schou, Soren, Stahli, Alexandra, Stavropoulos, Andreas, "Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018" in Clinical Oral Implants Research, 29 (2018):93-99, https://doi.org/10.1111/clr.13270 . .